98 related articles for article (PubMed ID: 7962351)
1. p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas.
Buckley N; Bates AS; Broome JC; Strange RC; Perrett CW; Burke CW; Clayton RN
J Clin Endocrinol Metab; 1994 Nov; 79(5):1513-6. PubMed ID: 7962351
[TBL] [Abstract][Full Text] [Related]
2. P53 protein accumulates in Cushings adenomas and invasive non-functional adenomas.
Buckley N; Bates AS; Broome JC; Strange RC; Perrett CW; Burke CW; Clayton RN
J Clin Endocrinol Metab; 1995 Feb; 80(2):4 p following 692. PubMed ID: 7852482
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 protein in pituitary adenomas.
Oliveira MC; Marroni CP; Pizarro CB; Pereira-Lima JF; Barbosa-Coutinho LM; Ferreira NP
Braz J Med Biol Res; 2002 May; 35(5):561-5. PubMed ID: 12011941
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical accumulation of p53 in corticotroph adenomas: relationship with heat shock proteins and apoptosis.
Kontogeorgos G; Kapranos N; Thodou E; Sambaziotis D; Tsagarakis S
Pituitary; 1999 May; 1(3-4):207-12. PubMed ID: 11081199
[TBL] [Abstract][Full Text] [Related]
6. Histone acetylation patterns of typical and atypical pituitary adenomas indicate epigenetic shift of these tumours.
Ebrahimi A; Schittenhelm J; Honegger J; Schluesener HJ
J Neuroendocrinol; 2011 Jun; 23(6):525-30. PubMed ID: 21453398
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas.
Green VL; White MC; Hipkin LJ; Jeffreys RV; Foy PM; Atkin SL
Eur J Endocrinol; 1997 Apr; 136(4):382-7. PubMed ID: 9150697
[TBL] [Abstract][Full Text] [Related]
8. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
11. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus.
Gandour-Edwards R; Kapadia SB; Janecka IP; Martinez AJ; Barnes L
Mod Pathol; 1995 Feb; 8(2):160-4. PubMed ID: 7777477
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
Tsagarakis S; Kontogeorgos G; Giannou P; Thalassinos N; Woolley J; Besser GM; Grossman A
Clin Endocrinol (Oxf); 1992 Aug; 37(2):163-7. PubMed ID: 1327588
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the in vitro secretory activity of human pituitary adenomas: modification of corticotropin release from adenoma tissue explant cultures by addition of a human plasma ultrafiltrate bioactive fraction.
Zarković N; Hayn M; Plavsić V; Zarković K; Paladino J; Hirsl N; Golubić J; Mikulandra S; Rogić D; Salzer B; Pokrić B; Schaur RJ; Tatzber F; Faulhammer H; Benko B; Dietrich W; Jurin M; Korsić M
Eur J Clin Chem Clin Biochem; 1996 Jan; 34(1):23-30. PubMed ID: 8704030
[TBL] [Abstract][Full Text] [Related]
15. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
17. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
18. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas.
Hentschel SJ; McCutcheon lE; Moore W; Durity FA
Can J Neurol Sci; 2003 Aug; 30(3):215-9. PubMed ID: 12945944
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in colorectal adenomas.
Kaklamanis L; Gatter KC; Mortensen N; Baigrie RJ; Heryet A; Lane DP; Harris AL
Am J Pathol; 1993 Jan; 142(1):87-93. PubMed ID: 7678722
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
